fbpx

Has the ACA Expanded Medicare’s Immunosuppressive Drug Coverage for Kidney Transplant Recipients?

2020-03-21T20:46:59+00:00November 18th, 2013|Categories: Immunosuppressive Drug Coverage, Patient's Voice|

By Jim Myers, DPC Patient Ambassador. I had a conversation with my doctor last week. (My nephrologist, Dr. Vavilala, we call him Dr. V). He asked me if I had heard anything during my last trip to Washington, D.C. about an extension of coverage through the ACA to kidney transplant patients of the immunosuppressive drug coverage beyond the 36 month period that currently exists. This rang a bell in the back of my brain, so I decided to check it out. Every transplant patient or transplant candidate knows the current status of the law. If you are a kidney transplant [...]

Congressional Corner: Two Transplant Bills Introduced in Congress

2020-03-21T20:47:21+00:00March 22nd, 2013|Categories: Access to Transplant, Immunosuppressive Drug Coverage, Improve Access to Care|Tags: |

By Carrie L., Director of Congressional and State Relations Recently, two bills relating to kidney and organ transplants have been introduced in Congress. Senator Richard Durbin of Illinois and Senator Thad Cochran of Mississippi introduced the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 (S. 323) in the Senate, and Congressman Michael Burgess and Congressman Ron Kind introduced a companion bill (H.R. 1325) in the House. If passed, these bills will extend Medicare immunosuppressive drug coverage for kidney transplant patients under 65 years old for the life of the graft. Under current law, Medicare beneficiaries who are [...]

Congressional Corner: Over the Cliff – Then Quickly Back Up Again

2020-03-21T20:47:40+00:00January 3rd, 2013|Categories: Blog, Immunosuppressive Drug Coverage, Transportation Services|

By Carrie L., Director of Congressional and State Relations Well, we went over the fiscal cliff. And then, just hours later a deal was struck, a few hours late but a deal to bring us back from the brink nonetheless. The 112th Congress concluded its tumultuous, and gridlocked 2 years by passing a deal to avoid massive tax hikes for the middle class and a 27% decrease in payments to Medicare providers on New Year’s Day. Unfortunately, cuts to the Medicare ESRD program were still included in the fiscal cliff package. The deal calls on the Centers for Medicare and Medicaid [...]

Congressional Corner: A Year of DPC Advocacy Successes!

2020-09-24T20:41:46+00:00December 12th, 2012|Categories: Immunosuppressive Drug Coverage, Medicaid, State Advocacy, Transportation Services|Tags: , |

By Carrie L., Director of Congressional and State Relations As 2012 comes to an end, DPC has a lot to celebrate and a lot to look forward to. DPC staff and most importantly our members, have achieved so much this year, bringing awareness to kidney disease issues both in Congress and in their communities! Patient Ambassadors held dozens of kidney and dialysis awareness events across the country in support of World Kidney Day and other events throughout the year. Patient Ambassadors taught members of their churches and civic organizations as well as youth in schools about the importance of keeping your [...]

From the Welcome Desk at DPC: November

2020-03-21T20:47:40+00:00November 28th, 2012|Categories: Blog, Immunosuppressive Drug Coverage|

By Stephen C., Administrative Assistant Hello all! I hope everyone’s doing well and you’re all ready for a wonderful (renal-friendly) holiday season. This week, I wanted to share my experience visiting the kind folks at ESRD Network 11 in Milwaukee for their annual meeting. I had a great time talking with nurses and patients about everything we do at DPC. I think my favorite moment during the whole event was when a nurse approached our table and asked me if we were doing anything about immunosuppressant drug coverage for transplant patients. She explained that the lack of immunosuppressant coverage was causing [...]

Health Reform Implementation Continues at the State Level

2020-09-24T20:43:02+00:00October 11th, 2012|Categories: Access to Transplant, Blog, Immunosuppressive Drug Coverage, State Advocacy|

By Carrie L., Director of Congressional and State Relations I have the unenviable job of trying to make state health reform both easy to understand and interesting, but I have given it my best shot. In this article I will be discussing two topics that are important for kidney disease patients, essential health benefit benchmark plans and the formation of state-based health insurance exchanges. State governments and health reform boards have been busy over the past couple of months determining how they will deal with implementing the Affordable Care Act (ACA) in their states. Deadlines have come and gone for [...]

DPC Urges Nevada Commission of Insurance to Not Make Cuts for Patients’ Modality, Transportation, Care and Treatment

2020-09-24T20:43:59+00:00September 27th, 2012|Categories: Access to Transplant, Comment Letter, Immunosuppressive Drug Coverage, Improve Access to Care, State Advocacy, Transplant Donor Protection, Treatment Options|

Scott J. Kipper Commissioner of Insurance State of Nevada 1818 E. College Parkway, Suite 103 Carson City, NV 89706 Dear Commissioner Kipper: As America’s largest patient-led organization representing dialysis patients, Dialysis Patient Citizens (DPC) works to improve the quality of life of all dialysis patients through education and advocacy. Today we are writing on behalf of the nearly 3,000 dialysis patients in Nevada to make sure that their health and interests are represented in the State’s essential health benefits plan. DPC is committed to improving patient health and quality of life and to that end, there are several important benefits [...]

Go to Top